OmniAb (OABI) Competitors $1.58 -0.02 (-1.25%) Closing price 09/24/2025 04:00 PM EasternExtended Trading$1.60 +0.02 (+1.27%) As of 09/24/2025 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OABI vs. RSKD, BWMN, IBTA, PHLT, NEXN, UXIN, ADV, PRTH, RMR, and THRYShould you be buying OmniAb stock or one of its competitors? The main competitors of OmniAb include Riskified (RSKD), Bowman Consulting Group (BWMN), Ibotta (IBTA), Performant Healthcare (PHLT), Nexxen International (NEXN), Uxin (UXIN), Advantage Solutions (ADV), Priority Technology (PRTH), The RMR Group (RMR), and Thryv (THRY). These companies are all part of the "business services" industry. OmniAb vs. Its Competitors Riskified Bowman Consulting Group Ibotta Performant Healthcare Nexxen International Uxin Advantage Solutions Priority Technology The RMR Group Thryv Riskified (NYSE:RSKD) and OmniAb (NASDAQ:OABI) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability. Which has more risk and volatility, RSKD or OABI? Riskified has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Comparatively, OmniAb has a beta of 0.14, indicating that its stock price is 86% less volatile than the S&P 500. Do analysts rate RSKD or OABI? Riskified currently has a consensus price target of $5.82, indicating a potential upside of 20.78%. OmniAb has a consensus price target of $6.67, indicating a potential upside of 321.94%. Given OmniAb's stronger consensus rating and higher possible upside, analysts plainly believe OmniAb is more favorable than Riskified.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Riskified 2 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.14OmniAb 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, RSKD or OABI? Riskified has higher revenue and earnings than OmniAb. Riskified is trading at a lower price-to-earnings ratio than OmniAb, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRiskified$327.52M2.37-$34.92M-$0.24-20.08OmniAb$26.39M8.62-$62.03M-$0.60-2.63 Is RSKD or OABI more profitable? Riskified has a net margin of -11.70% compared to OmniAb's net margin of -275.83%. Riskified's return on equity of -8.27% beat OmniAb's return on equity.Company Net Margins Return on Equity Return on Assets Riskified-11.70% -8.27% -6.43% OmniAb -275.83%-22.79%-20.18% Does the media prefer RSKD or OABI? In the previous week, Riskified and Riskified both had 1 articles in the media. Riskified's average media sentiment score of 1.90 beat OmniAb's score of 0.00 indicating that Riskified is being referred to more favorably in the media. Company Overall Sentiment Riskified Very Positive OmniAb Neutral Do institutionals and insiders hold more shares of RSKD or OABI? 59.0% of Riskified shares are held by institutional investors. Comparatively, 72.1% of OmniAb shares are held by institutional investors. 17.4% of Riskified shares are held by company insiders. Comparatively, 8.6% of OmniAb shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryRiskified beats OmniAb on 9 of the 14 factors compared between the two stocks. Get OmniAb News Delivered to You Automatically Sign up to receive the latest news and ratings for OABI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OABI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OABI vs. The Competition Export to ExcelMetricOmniAbMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$230.33M$2.56B$5.78B$10.42BDividend YieldN/A56.32%5.68%4.61%P/E Ratio-2.6323.6376.0126.42Price / Sales8.62750.89560.21127.79Price / CashN/A174.1537.5661.52Price / Book0.675.2913.046.39Net Income-$62.03M$32.95M$3.29B$271.13M7 Day Performance-4.82%1.40%0.84%0.93%1 Month Performance-3.07%6.35%5.04%7.52%1 Year Performance-62.29%2.70%69.67%30.06% OmniAb Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OABIOmniAb1.7931 of 5 stars$1.58-1.3%$6.67+321.9%-62.8%$230.33M$26.39M-2.637RSKDRiskified3.0713 of 5 stars$4.51-1.2%$5.82+29.2%+0.0%$727.70M$327.52M-18.81780Positive NewsBWMNBowman Consulting Group1.7891 of 5 stars$41.78-0.1%$38.17-8.6%+83.3%$720.62M$426.56M69.632,200News CoverageIBTAIbotta2.8889 of 5 stars$26.53+1.0%$34.71+30.8%N/A$670.15M$367.25M9.21N/APHLTPerformant Healthcare1.302 of 5 stars$7.69flat$7.88+2.4%N/A$618.58M$122.98M-769.00930Positive NewsNEXNNexxen International4.0479 of 5 stars$9.64-0.2%$15.00+55.7%+13.3%$611.62M$365.48M15.31895UXINUxin0.9694 of 5 stars$3.25-2.4%N/A+42.6%$610.95M$1.63B-16.25810Gap UpADVAdvantage Solutions2.2231 of 5 stars$1.82-7.4%$2.25+24.0%-53.0%$591.60M$3.57B-1.9369,000Positive NewsPRTHPriority Technology4.4945 of 5 stars$7.36-1.1%$13.00+76.7%-0.1%$588.20M$918.56M28.311,019Positive NewsRMRThe RMR Group2.3187 of 5 stars$17.02+0.2%$24.00+41.0%-35.7%$540.77M$897.20M14.50600THRYThryv2.5411 of 5 stars$12.11-0.8%$21.40+76.7%-31.8%$531.41M$758.29M-5.103,016 Related Companies and Tools Related Companies Riskified Alternatives Bowman Consulting Group Alternatives Ibotta Alternatives Performant Healthcare Alternatives Nexxen International Alternatives Uxin Alternatives Advantage Solutions Alternatives Priority Technology Alternatives The RMR Group Alternatives Thryv Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OABI) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OmniAb, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OmniAb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OABI Stock Alerts